Elos Medtech Sustainability Profile
Elos Medtech, a prominent player in the medical technology industry, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 1997, the company has established itself as a leader in the development and manufacturing of advanced medical devices, particularly in orthopaedics and dental applications. Elos Medtech is renowned for its innovative solutions, including precision-engineered implants and instruments that cater to the specific needs of healthcare professionals. The company’s commitment to quality and sustainability sets it apart in a competitive market, ensuring that its products meet the highest standards of safety and efficacy. With a strong market position and a reputation for excellence, Elos Medtech continues to achieve significant milestones, contributing to advancements in patient care and enhancing the overall healthcare landscape.
DitchCarbon Score
How does Elos Medtech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elos Medtech's score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elos Medtech's reported carbon emissions
In 2024, Elos Medtech reported total carbon emissions of approximately 13,185,000 kg CO2e globally. This figure represents a significant increase from the 2023 global emissions of about 8,639,000 kg CO2e. The 2023 emissions from their operations in China were approximately 8,600,000 kg CO2e, while in 2022, global emissions were about 6,795,000 kg CO2e, indicating a trend of rising emissions over the years. Elos Medtech has not disclosed specific data regarding Scope 1, 2, or 3 emissions, nor have they set any formal reduction targets or initiatives as part of their climate commitments. The absence of such targets suggests a need for further development in their sustainability strategy. The company’s emissions data is sourced directly from Elos Medtech AB (publ) and does not appear to be cascaded from any parent or related organization. As of now, Elos Medtech has not publicly committed to any industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or similar frameworks. Overall, while Elos Medtech has reported substantial emissions figures, the lack of reduction targets highlights an area for potential improvement in their climate strategy.
How Carbon Intensive is Elos Medtech's Industry?
How Carbon Intensive is Elos Medtech's Location?
Elos Medtech's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elos Medtech has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
